Lidocaine hydrochloride 2% w/v oromucosal topical solution
CGR-BR-015 · ANVISA — Formulário Nacional da Farmacopeia Brasileira, 2ª edição, Revisão 02 (2012)
HISTORICAL SOURCE EDITION — compare with the current edition before use.
Source formula
| Ingredient | Source quantity |
|---|---|
| Lidocaine hydrochloride | 2 g |
| Sodium saccharin | 0.1 g |
| FNFB paraben concentrate | 2.5 g |
| Purified water | q.s. ad 100 mL |
Quantities refer to the source batch. This website does not automatically scale formulas, assign doses or calculate BUD.
Description
Partial evidenceOromucosal preparation: Lidocaine hydrochloride 2% w/v oromucosal topical solution. Additional appearance criteria are not established by the specific text reviewed.
References: [1]
Use and action
Documented in sourceTopical anaesthesia of oral mucosa.
References: [1]
Specifications
Not establishedNo specific information is established by the consulted sources. Complete this before local approval where critical to this preparation.
References: [1]
Light
Partial evidenceProtect lidocaine hydrochloride from light.
For the finished product the source specifies:
Well-closed opaque plastic or amber glass, protected from light, room temperature.
Air
Not establishedNo specific information is established by the consulted sources. Complete this before local approval where critical to this preparation.
References: [1]
Water and solubility
Not establishedNo specific information is established by the consulted sources. Complete this before local approval where critical to this preparation.
References: [1]
Humidity
Not establishedNo specific information is established by the consulted sources. Complete this before local approval where critical to this preparation.
References: [1]
Temperature
Not establishedNo specific information is established by the consulted sources. Complete this before local approval where critical to this preparation.
References: [1]
pH and related incompatibilities
Not establishedNo specific information is established by the consulted sources. Complete this before local approval where critical to this preparation.
References: [1]
Other incompatibilities
Partial evidenceLidocaine HCl adsorption to PVC depends on pH/temperature; assess the specific container material.
References: [2]
Ingredient-specific information
Partial evidenceLidocaine hydrochloride: Protect lidocaine hydrochloride from light.
These are selected facts for identified ingredients; relevant sensitivities and incompatibilities are detailed in the corresponding fields. This is not a complete SDS for every material.
References: [2]
Personal protective equipment
Partial evidenceComplete formula-specific PPE is not specified. Select gloves, eye protection and exposure controls using the exact materials’ SDS and the local risk assessment.
Supplementary AEMPS framework: clean long-sleeved laboratory clothing, hair covering and dedicated footwear/overshoes. Powder handling requires suitable eye/respiratory protection; change gloves with activity or damage. Select the exact type/material using SDS and risk assessment.
Risks and precautions
Partial evidenceA complete formula-specific hazard classification is not established. Assess potency, dust/aerosol, allergens, solvents, microbial risk and cross-contamination using the actual materials and process. Absence of a flag does not establish absence of hazard.
References: [1]
Compounding conditions
Partial evidenceFollow the addition sequence, temperatures and times stated under Preparation Procedure. The specific monograph is not a complete qualification of the local facility/equipment.
References: [1]
BUD rationale
Not establishedNo specific information is established by the consulted sources. Complete this before local approval where critical to this preparation.
The source period applies to its exact composition, method and packaging. It is not this batch’s expiry date and cannot be transferred to another vehicle/strength. Calculate the actual date in the blank batch record.
References: [1]
Bases and dependencies
Documented in sourceParaben concentrate 6% + 3% w/w → CGR-BR-001
References: [1]
Equipment
Editorial checklistIndicative checklist derived from the method: Balance of suitable resolution, Containers and mixing tools compatible with the materials, Suitable filtration medium. Selection/qualification is defined locally.
References: [1]
Preparation procedure
Documented in sourceDissolve lidocaine hydrochloride and saccharin in water. Add preservative, make to volume, mix and filter.
References: [1]
Observations
Documented in sourceTopical oromucosal use; do not swallow. Not an injection. Historical source dosing is not reproduced.
References: [1]
Packaging
Documented in sourceWell-closed opaque plastic or amber glass, protected from light, room temperature.
References: [1]
Quality control
Not establishedNo specific information is established by the consulted sources. Complete this before local approval where critical to this preparation.
References: [1]
Storage
Documented in sourceWell-closed opaque plastic or amber glass, protected from light, room temperature.
References: [1]
Dispensing and directions
Documented in sourceDo not swallow. In children, use only on medical advice with adult supervision.
References: [1]
Labelling
editorial_specimenLidocaine hydrochloride 2% w/v oromucosal topical solution
Strength/variant: __________ Quantity: __________
Batch: __________ Prepared: __________ Use by: __________
Στοματοβλεννογόνια χρήση / Oromucosal use
Dose/directions: __________
Storage: Well-closed opaque plastic or amber glass, protected from light, room temperature.
Do not swallow. In children, use only on medical advice with adult supervision.
References: [1]
Sources and traceability
- ANVISA — Formulário Nacional da Farmacopeia Brasileira, 2ª edição, Revisão 02 (2012)
2012, 2nd ed., Rev. 02 — superseded · PDF pp. 98 · A2
Review date reported in supplied metadata: 2026-09-10
- FN/2003/PA/020 LIDOCAÍNA, HIDROCLORURO DE
Διαθέσιμο κείμενο / Retrieved text · PDF pp. 1–2 · A1
Review date reported in supplied metadata: 2026-09-10
- PN/L/PG/002/00 INDUMENTARIA
Διαθέσιμο κείμενο / Retrieved text · PDF pp. 1–5 · A1
Review date reported in supplied metadata: 2026-09-10
Provenance and reuse
This record comes from the supplied v4 collection. Primary-source rights and licences remain separate. No new comprehensive licence review has been performed for the earlier 239 records.
SHA-256 of the supplied PDF: 6f4f1c826f4e975289bd1b71091578a4021a0bd1eb495622d577fafe5b7f04e6